Fact CheckerSign in

NCT07652190Not yet recruiting

Comparison of Day Hospitalization Versus Full-Time Hospitalization in the Treatment of Severe Adolescent Obesity

Comparison of Day Hospitalization and Full-Time Hospitalization in the Treatment of Severe Adolescent Obesity (MAROSA)

Source: ClinicalTrials.gov · Last updated 16 Jun 2026

Brief summary (registry, in English)

This multicenter prospective quasi-experimental study aims to compare the effectiveness of day hospitalization versus full-time hospitalization for adolescents with severe obesity. The primary outcome is the change in BMI z-score measured six months after the end of treatment.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
126 (estimated)
First submitted
12 May 2026
Start date
5 Oct 2026
Primary completion date
10 Oct 2027
Lead sponsor
Fondation Santé des Étudiants de France
Diseases
Obesity
NCT number
NCT07652190

What you commit to

  • Study type: Interventional
  • Planned participants: 126
  • From 5 Oct 2026 to the primary completion date, 10 Oct 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Acute psychiatric disorder requiring hospitalization
  • Secondary obesity due to endocrine disorders

Age

  • Age \< 12 or \> 20 years

Other

  • Inability to provide consent Emergency situation Refusal to participate

Who the study is looking for

  • Adolescents aged 12-20 years
  • Severe obesity (IOTF \> 30)
  • Admitted to participating centers
  • Covered by health insurance
  • Signed informed consent (participant or legal guardian)

Age in the registry: 12 years to 20 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.